Published Date : 2024-Jul-20
The Area of cancer treatment is experiencing a major change, fueled by progress in genetic technologies. With a better grasp of how cancer works at the molecular level, genomics is at the heart of tailoring therapies, forecasting patient results, and creating new approaches to treatment. This article delves into the latest developments, prospects, and what lies ahead for the genetic aspects of cancer treatment.
Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By End-use, COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
Top 10 companies in the Genomics In Cancer Care Market by Intellectual Market Insights Research
The area of cancer treatment is experiencing a major change, fueled by progress in genetic technologies. With a better grasp of how cancer works at the molecular level, genomics is at the heart of tailoring therapies, forecasting patient results, and creating new approaches to treatment. This article delves into the latest developments, prospects, and what lies ahead for the genetic aspects of cancer treatment.
Understanding Genomics in Cancer Care
Genomics is the field that focuses on examining a person's DNA and how it interacts. In the context of cancer treatment, this entails looking into the genetic alterations and differences that contribute to the growth and spread of cancer. By pinpointing these genetic modifications, medical professionals can customize therapies to attack particular mutations, resulting in more successful and safer treatments.
According to a comprehensive study by Intellectual Market Insights Research, the global Genomics In Cancer Care Market size was valued at USD 12.17 Billion in 2021 and is projected to reach USD 40.52 Billion by 2028.
Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By End-use, COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
Growing at a CAGR of 16.23% from 2022 to 2028.
Get Insight: https://bit.ly/4feDJt1
Genomics In Cancer Care Market Players Analysis: Thermo Fisher Scientific Inc., Intrexon Bioinformatics Germany GmbH, Affymetrix, Agilent Technologies, BGI, Bio-Rad Laboratories, Cancer Genetics Inc, GE Healthcare, Illumina Inc, Life Technologies, Myriad Genetics, Pacific Biosciences, Perkin Elmer, Qiagen, Quest Diagnostics, Roche Diagnostics, Sigma Aldrich and Others.
Founded: 1956
Headquarters: Waltham, Massachusetts, United States
Website: https://www.thermofisher.com/
About Us:
The company had nearly 125,000 employees and had revenue of $45.95 Billion.
Founded: 1999
Headquarters: Santa Clara, California, United States
Website: https://www.agilent.com/
About Us:
The company had nearly 18,000 employees and had revenue of $7.39 Billion.
Founded: 1999
Headquarters: Shenzhen, Guangdong, China
Website: https://www.genomics.cn/
About Us:
The company had nearly 7,000 employees and had revenue of $.96 Billion.
Founded: 1952
Headquarters: Hercules, California, USA
Website: https://www.bio-rad.com/
About Us: Bio-Rad Laboratories is a leading global provider of life science research and clinical diagnostics products. The company offers innovative tools and services to advance scientific research and healthcare.
The company had nearly 8,030 employees and had revenue of $2.8 Billion.
Founded: 1892
Headquarters: Chicago, Illinois, USA
Website: https://www.gehealthcare.com/
About Us: GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. The company is dedicated to creating a world where healthcare has no limits.
The company had nearly 50,000 employees and had revenue of $18.34 Billion.
Founded: 1998
Headquarters: San Diego, California, USA
Website: https://www.illumina.com/
About Us: Illumina is a global leader in genomics, focused on transforming human health by unlocking the power of the genome. Their technologies are used for applications in life sciences, oncology, reproductive health, and other areas to enable groundbreaking discoveries and personalized healthcare.
The company had nearly 10,000 employees and had revenue of $4.58 Billion.
Founded: 1991
Headquarters: Salt Lake City, Utah, USA
Website: https://www.myriad.com/
About Us: Myriad Genetics is a molecular diagnostic company that develops and markets predictive medicine, personalized medicine, and prognostic medicine tests. They focus on providing critical information that guides health care decisions for patients and providers.
The company had nearly 2,100 employees and had revenue of $690 Billion.
Founded: 2004
Headquarters: Menlo Park, California, USA
Website: https://www.pacb.com/
About Us: Pacific Biosciences, also known as PacBio, develops and manufactures advanced sequencing systems to help scientists resolve genetically complex problems. Their technology enables high-quality, long-read sequencing data that enhances the understanding of biology.
The company had nearly 600 employees and had revenue of $200 Million.
Founded: 1937
Headquarters: Waltham, Massachusetts, USA
Website: https://www.perkinelmer.com/
About Us: PerkinElmer is a global leader focused on improving human and environmental health. They provide innovative detection, imaging, informatics, and service capabilities, enabling customers to gain critical insights in the areas of diagnostics, life sciences, and applied markets.
The company had nearly 16,000 employees and had revenue of $4.5 Billion.
Founded: 1984
Headquarters: Hilden, Germany
Website: https://www.qiagen.com/
About Us: Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. They offer innovative products and solutions that enable customers to unlock insights from the building blocks of life.
The company had nearly 5,300 employees and had revenue of $2.2 Billion.
Founded: 1967
Headquarters: Secaucus, New Jersey, USA
Website: https://www.questdiagnostics.com/
About Us: Quest Diagnostics is a leading provider of diagnostic information services. They offer a broad range of clinical testing and services, providing critical information that improves health outcomes and healthcare decisions. They also focus on developing innovative diagnostic solutions that enhance healthcare quality and efficiency.
The company had nearly 50,000 employees and had revenue of $9.88 Billion.
Founded: 1896
Headquarters: Basel, Switzerland
Website: https://diagnostics.roche.com/
About Us: Roche Diagnostics is a division of Roche, a global pioneer in pharmaceuticals and diagnostics. They provide innovative diagnostic solutions that help to improve patient care, offering a wide range of products and services that help healthcare providers, researchers, and laboratories around the world.
The company had nearly 100,000 employees and had revenue of $18.7 Billion.
Founded: 1975
Headquarters: St. Louis, Missouri, USA
Website: https://www.sigmaaldrich.com/
About Us: Sigma-Aldrich is a leading Life Science and High Technology company, now part of Merck Group. They provide a range of products and services to scientists and technologists in the fields of life science, biopharma, and other advanced materials sectors. Their solutions help accelerate scientific research and innovation.
The company had nearly 22,000 employees and had revenue of $8.1 Billion.
The field of genomics is revolutionizing the realm of cancer treatment, providing patients with renewed hope through the development of personalized and targeted therapies. As the market for genomics in cancer care progresses, it unveils considerable prospects for innovation, collaboration, and enhanced patient outcomes. By confronting the challenges and capitalizing on the opportunities, stakeholders have the potential to spearhead the forthcoming advancements in this essential area.
Browse Full Report: https://bit.ly/3YaZ3ty
